|
Application of Canadian hereditary renal cell carcinoma risk criteria to a population database. |
|
|
Stock and Other Ownership Interests - Teva |
Travel, Accommodations, Expenses - MSD; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Merck |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen; Merck |
Research Funding - Bristol-Myers Squibb |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Sanofi |
Consulting or Advisory Role - AstraZeneca; Janssen; Sanofi |
Travel, Accommodations, Expenses - Janssen; Sanofi |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - AstraZeneca |
|
|
Consulting or Advisory Role - Novartis; Pfizer |
Research Funding - Bristol-Myers Squibb (Inst) |
|
|
Employment - Impact Genetics (I) |
Leadership - Impact Genetics (I) |
Stock and Other Ownership Interests - Impact Genetics (I) |
Honoraria - Janssen Oncology; Myriad Genetics; Pfizer |
Consulting or Advisory Role - Theralase |
Research Funding - Olympus Medical Systems (Inst) |
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device |
|
|
Research Funding - Aragon Pharmaceuticals (I); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche Canada (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer |
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst) |
|
|
Honoraria - Astellas Pharma; Janssen; Novartis; Pfizer |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Novartis |
|
|
Honoraria - Amgen; Astellas Pharma; Janssen |
Speakers' Bureau - Amgen; Astellas Pharma; Janssen |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; Ferring; Merck; Novartis; Roche; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Pfizer |